类风湿关节炎与焦磷酸钙沉积病共存:系统文献综述
该系统综述检索至2026年1月,纳入24项研究共404例类风湿关节炎(RA)与焦磷酸钙沉积(CPPD)共存患者,其中98.3%年龄超过60岁。在365例有血清状态数据的患者中,60.2%为血清阴性;271例有影像学软骨钙化者中94.4%存在软骨钙化。最常用药物为甲氨蝶呤和泼尼松龙。
要点
- RA与CPPD可共存于老年患者,且常表现为血清阴性。
- 共存患者中影像学软骨钙化比例高(94.4%)。
- 甲氨蝶呤和泼尼松龙是最常处方的药物。
核心结论
- RA与CPPD可在老年患者中共存,且RA常为血清阴性,但现有研究样本量小,需更高质量研究确定共存患病率。
研究设计与样本
- 系统文献综述,检索EMBASE、MEDLINE、Scopus、PubMed、CINAHL和Cochrane数据库从建库至2026年1月31日,纳入24项研究(12项横断面研究、2项病例系列、10项病例报告)。
主要发现
- 共404例患者同时患有RA和CPPD,其中397/404(98.3%)年龄超过60岁。
- 365例有血清状态数据的患者中,204/339(60.2%)类风湿因子(RF)和抗环瓜氨酸蛋白抗体(ACPA)均阴性。
- 271/287(94.4%)患者影像学可见软骨钙化;271例软骨钙化患者中162例(59.8%)RF和ACPA均阴性。
- 最常处方药物为甲氨蝶呤75/205(36.6%)和泼尼松龙64/205(31.2%),秋水仙碱处方于24/205(11.7%)患者。
临床怎么用
- 对老年RA患者应警惕CPPD共存可能,尤其血清阴性且影像学显示软骨钙化者。
局限性
- 纳入研究样本量小,证据质量有限,需更高质量研究确定共存患病率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rheumatoid arthritis (RA) and calcium pyrophosphate deposition (CPPD) disease are forms of inflammatory arthritis which may have similar presentations. There is growing recognition that these conditions can coexist, especially in elderly patients. This systematic literature review aims to examine the epidemiology and clinical characteristics of patients with both RA and CPPD disease. METHODS: A systematic literature search was performed from database inception to 31st January 2026 using the databases EMBASE, MEDLINE, Scopus, PubMed, CINAHL, and Cochrane. Keywords relating to RA, CPPD and chondrocalcinosis were used. Inclusion criteria were studies published in English and those that addressed the co-occurrence of RA and CPPD. RESULTS: The search yielded 24 studies comprising 12 cross-sectional studies, 2 case series, and 10 case reports published between 1965 and 2026. A total of 404 patients had both RA and CPPD, with 397/404 (98.3%) aged over 60 years old. Of 365 patients with serostatus data, 204/339 (60.2%) were seronegative for both rheumatoid factor (RF) and anti-citrullinated protein antibody (ACPA). Radiographic chondrocalcinosis was evident in 271/287 (94.4%). Of 271 patients with chondrocalcinosis, 162 (59.8%) were seronegative for both RF and ACPA. The most prescribed medications were methotrexate and prednisolone, in 75/205 (36.6%) and 64/205 (31.2%) patients, respectively. Colchicine was prescribed for 24/205 (11.7%). CONCLUSION: While the studies were small, RA, which is commonly seronegative, and CPPD can co-exist in the elderly. Higher-quality studies are required to determine the prevalence of co-existent RA and CPPD, thereby improving insight into the epidemiology and potentially enhancing outcomes of these patients.
引用
- Hong LE, Weng J, Bursill D, et al. Co-occurrence of rheumatoid arthritis and calcium pyrophosphate deposition disease: A systematic literature review. Semin Arthritis Rheum. 2026. PMID: 42556248. doi:10.1016/j.semarthrit.2026.153047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。